Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alessandro Doria, M.D., Ph.D.

Concepts (599)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Alessandro Doria's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Alessandro Doria has written about over time.
Diabetes Mellitus, Type 1, 37 publications between 1987 and 2021, average publication date January 2002. Genetic Markers, 8 publications between 1998 and 2018, average publication date January 2005. Diabetic Nephropathies, 24 publications between 1992 and 2022, average publication date September 2008. Diabetic Angiopathies, 10 publications between 1996 and 2018, average publication date August 2009. Glomerular Filtration Rate, 18 publications between 1987 and 2023, average publication date February 2010. Polymorphism, Single Nucleotide, 37 publications between 2002 and 2022, average publication date August 2010. Diabetes Mellitus, Type 2, 86 publications between 1992 and 2023, average publication date October 2010. Coronary Disease, 8 publications between 1990 and 2022, average publication date March 2011. Diabetes Mellitus, 8 publications between 1996 and 2020, average publication date April 2013. Hyperuricemia, 2 publications between 2011 and 2018, average publication date October 2014. Uric Acid, 8 publications between 2010 and 2020, average publication date December 2015. Glutamate-Ammonia Ligase, 3 publications between 2013 and 2020, average publication date June 2016. Allopurinol, 5 publications between 2013 and 2020, average publication date June 2018. Glucagon-Like Peptide 1, 2 publications between 2017 and 2019, average publication date November 2018. Anemia, Megaloblastic, 1 publications between 2019 and 2019, average publication date March 2019. Fenofibrate, 4 publications between 2017 and 2020, average publication date May 2019. Gout Suppressants, 2 publications between 2018 and 2020, average publication date June 2019. Haptoglobins, 1 publications between 2020 and 2020, average publication date June 2020. Xanthine Oxidase, 1 publications between 2020 and 2020, average publication date June 2020. Renal Insufficiency, Chronic, 4 publications between 2020 and 2023, average publication date September 2021.

To see the data from this visualization as text, click here.
Doria's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (599)
Explore
_
Co-Authors (66)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.